Concepedia

A phase I study of full-dose gemcitabine and regional arterial infusion of nafamostat mesilate for advanced pancreatic cancer

Tadashi Uwagawa, Takeyuki Misawa, Taro Sakamoto, Ryusuke Ito, Takeshi Gocho, Hiroaki Shiba, Shigeki Wakiyama, Shoichi Hirohara, Shunichi Sadaoka, Katsuhiko Yanaga

Annals of Oncology · 2008 · 44 citations · 18 references

DOIFull text

Open access

Concepts

References

18

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer

Gershon Y. Locker, Stanley R. Hamilton, Jules E. Harris et al. · Journal of Clinical Oncology · 2006 · 1.6K citations

, , +8

Accelerated Titration Designs for Phase I Clinical Trials in Oncology

Richard Simon, Larry Rubinstein, Susan G. Arbuck et al. · JNCI Journal of the National Cancer Institute · 1997 · 640 citations · Full text

, , +17

Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway

Nathalie Vergnolle, Nigel W. Bunnett, Keith A. Sharkey et al. · Nature Medicine · 2001 · 472 citations

, , +14